Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients an observational study

BMC Nephrology

Volumn 10, Issue 1, 2009, Pages

  Fassett, Robert G ^a,b,d   Driver, Ritza ^b   Healy, Helen ^a   Ranganathan, Dwarakanathan ^a   Ratanjee, Sharad ^a   Robertson, Iain K ^c   Geraghty, Dominic P ^c   Sharman, James E ^d   Coombes, Jeff S ^b,d  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b LAUNCESTON GENERAL HOSPITAL   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROSTANE DERIVATIVE; PENTRAXIN 3; C REACTIVE PROTEIN; DIAGNOSTIC AGENT; GLYCERYL TRINITRATE; SERUM AMYLOID P;

ADULT; AORTA; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; AUGMENTATION INDEX; BLOOD FLOW VELOCITY; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; ECHOCARDIOGRAPHY; FATTY ACID BLOOD LEVEL; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PROTEIN BLOOD LEVEL; SYSTOLE; TISSUE STRUCTURE; ATHEROSCLEROSIS; BLOOD; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; HEART LEFT VENTRICLE FUNCTION; INTIMA; MANOMETRY; METHODOLOGY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PATIENT SELECTION; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; TUNICA MEDIA; ULTRASTRUCTURE;

ATHEROSCLEROSIS; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CAROTID ARTERIES; CLINICAL TRIALS AS TOPIC; ECHOCARDIOGRAPHY; F2-ISOPROSTANES; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MANOMETRY; MULTICENTER STUDIES AS TOPIC; NITROGLYCERIN; OXIDATIVE STRESS; PATIENT SELECTION; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RESEARCH DESIGN; SERUM AMYLOID P-COMPONENT; TUNICA INTIMA; TUNICA MEDIA; VENTRICULAR FUNCTION, LEFT;

EID: 64249140164     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-10-8     Document Type: Article

References (30)

1. Oxidative stress in uremia. J Himmelfarb RM Hakim, Curr Opin Nephrol Hypertens 2003 12 6 593 598 10.1097/00041552-200311000-00004 14564195
2. Inflammation in end-stage renal disease: the hidden enemy. P Stenvinkel, Nephrology (Carlton) 2006 11 1 36 41 10.1111/j.1440-1797.2006.00541.x 16509930
3. Causes and consequences of increased arterial stiffness in chronic kidney disease patients. P Gusbeth-Tatomir A Covic, Kidney Blood Press Res 2007 30 2 97 107 10.1159/000100905 17374960
4. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis. L Segall A Covic, Nephrol Dial Transplant 2007 22 1 59 63 10.1093/ndt/gfl643 17099221
5. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. W Van Biesen F Verbeke R Vanholder, Nephrol Dial Transplant 2007 22 1 53 58 10.1093/ndt/gfl601 17050633
6. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. BG Jaar J Coresh LC Plantinga NE Fink MJ Klag AS Levey NW Levin JH Sadler A Kliger NR Powe, Ann Intern Med 2005 143 3 174 183 16061915
7. Vascular calcification and cardiovascular function in chronic kidney disease. M Sigrist P Bungay MW Taal CW McIntyre, Nephrol Dial Transplant 2006 21 3 707 714 10.1093/ndt/gfi236 16263735
8. Carotid atherosclerosis and cardiovascular risk factors in hemodialysis and peritoneal dialysis patients. FM Yilmaz H Akay M Duranay G Yilmaz PS Oztekin U Kosar N Tekeli M Altay H Parpucu D Yucel, Clin Biochem 2007 40 18 1361 1366 10.1016/j.clinbiochem.2007.07.017 17936258
9. Impact of aortic stiffness on survival in end-stage renal disease. J Blacher AP Guerin B Pannier SJ Marchais ME Safar GM London, Circulation 1999 99 18 2434 2439 10318666
10. Oxidation of low density lipoproteins from patients with renal failure or renal transplants. WH Sutherland RJ Walker MJ Ball SA Stapley MC Robertson, Kidney Int 1995 48 1 227 236 10.1038/ki.1995.288 7564083
11. Oxidant stress and antioxidant capacity in urine of renal transplant recipients predict early graft function. DA Shoskes AR Shahed S Kim HA Gritsch G Danovitch A Wilkinson, Transplant Proc 2001 33 12 984 10.1016/S0041-1345(00) 02297-1 11267157
12. Serum paraoxonase activity changes in uremic and kidney-transplanted patients. G Paragh L Asztalos I Seres Z Balogh L Locsey I Karpati J Matyus E Katona M Harangi G Kakuk, Nephron 1999 83 2 126 131 10.1159/000045489 10516491
13. Increased low density lipoprotein oxidation in stable kidney transplant recipients. H Ghanem MA van den Dorpel W Weimar AJ Man in 'T Veld MH El-Kannishy H Jansen, Kidney International 1996 49 2 488 493 10.1038/ki.1996.69 8821834
14. Oxidation of low-density lipoproteins in renal transplant recipients. F Cofan D Zambon C Rodriguez JC Laguna M Vazquez E Casals J Torregrosa E Ros F Oppenheimer, Transplantation Proceedings 1999 31 6 2333 2334 10.1016/S0041-1345(99)00365-6 10500604
15. Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease. ZA Massy C Maziere S Kamel M Brazier G Choukroun C Tribouilloy M Slama M Andrejak JC Maziere, Pediatr Nephrol 2005 20 3 380 382 10.1007/s00467-004-1623-9 15549414
16. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. IB Wilkinson SA Fuchs IM Jansen JC Spratt GD Murray JR Cockcroft DJ Webb, J Hypertens 1998 16 12 Pt 2 2079 2084 10.1097/00004872- 199816121-00033 9886900
17. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. TA Mori KD Croft IB Puddey LJ Beilin, Anal Biochem 1999 268 1 117 125 10.1006/abio.1998.3037 10036170
18. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. MS Rolph S Zimmer B Bottazzi C Garlanda A Mantovani GK Hansson, Arterioscler Thromb Vasc Biol 2002 22 5 e10 14 10.1161/01.ATV.0000015595.95497. 2F 12006411
19. Carotid intima-media thickness testing: technical considerations. CK Mitchell SE Aeschlimann CE Korcarz, J Am Soc Echocardiogr 2004 17 6 690 692 10.1016/j.echo.2004.03.019 15163947
20. Non-invasive measurement of surrogate markers of atherosclerosis: carotid intima thickness (c-IMT). T Chodakauskas, GE Healthcare 2006
21. Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis. T Stompor A Krasniak W Sulowicz A Dembinska-Kiec K Janda K Wojcik B Tabor ME Kowalczyk-Michalek A Zdzienicka E Janusz-Grzybowska, Nephrol Dial Transplant 2005 20 2 404 412 10.1093/ndt/gfh597 15618238
22. Ultrasound brachial artery reactivity testing: technical considerations. SE Aeschlimann CK Mitchell CE Korcarz, J Am Soc Echocardiogr 2004 17 6 697 699 10.1016/j.echo.2004.03.017 15163949
23. No relationship between low-density lipoproteins and endothelial function in hemodialysis patients. BS Dalton RG Fassett DP Geraghty R De Ryke JS Coombes, Int J Cardiol 2005 99 2 307 314 10.1016/j.ijcard.2004.02.004 15749192
24. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. RM Lang M Bierig RB Devereux FA Flachskampf E Foster PA Pellikka MH Picard MJ Roman J Seward JS Shanewise, J Am Soc Echocardiogr 2005 18 12 1440 1463 10.1016/j.echo.2005.10.005 16376782
25. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. NB Schiller PM Shah M Crawford A DeMaria R Devereux H Feigenbaum H Gutgesell N Reichek D Sahn I Schnittger, J Am Soc Echocardiogr 1989 2 5 358 367 2698218
26. Echocardiography The normal Examination and Echocardiographic Measurements. B Anderson, Fergies Second 2007
27. Validation of a generalized transfer function to noninvasively derive central blood pressure during exercise. JE Sharman R Lim AM Qasem JS Coombes MI Burgess J Franco P Garrahy IB Wilkinson TH Marwick, Hypertension 2006 47 6 1203 1208 10.1161/01.HYP.0000223013.60612.72 16651459
28. Pulse wave analysis is a reproducible technique for measuring central blood pressure during hemodynamic perturbations induced by exercise. DJ Holland JW Sacre SJ McFarlane JS Coombes JE Sharman, Am J Hypertens 2008 21 10 1100 1106 10.1038/ajh.2008.253 18719622
29. Role of the augmentation index in hypertension. M Shimizu K Kario, Ther Adv Cardiovasc Dis 2008 2 1 25 35 10.1177/1753944707086935 19124405
30. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. IB Wilkinson SS Franklin IR Hall S Tyrrell JR Cockcroft, Hypertension 2001 38 6 1461 1466 10.1161/hy1201.097723 11751736